Biotech Beverage Company May Be Poised To Run Print E-mail
By M.E.Garza   
Wednesday, 24 March 2010 12:32
During the past couple of weeks, a few interesting things have happened to this very undervalued "bottom play" in the biotech sector.

Millennium Biotechnologies Group Inc. (MBTG.OB),  has not only been going through a very comprehensive capital restructuring, the company which engages in the research, development, and marketing of  products for the Clinical Nutrition and Sports Supplement Markets appears to be getting ready to go prime time.

Just a few days ago, they announced that they officially changed their name to Inergetics, Inc.

There is some well sourced chatter that they are close to signing a popular sports figure to endorse their Surgex brand nutritional support formula for athletes.

Intriguing also, is the fact that Ken Sadowsky, a distinguished expert and veteran of the Beverage Industry, has recently rejoined the Company's board of directors. Sadowsky's expertise in functional beverages and his well established relationships with key financing contacts in the industry are extremely important to what the company is getting ready to do- which is grow, secure a major distributor and boost profits.

Sadowsky is the Senior Beverages Advisor for Verlinvest, a Brussels-based holding company established by the founding family of Interbrew, currently known as Anheiser Busch InBev. The groundwork is now there for a potential investment into the company- similar to the one that Verlinvest made in 2002 when they put money into Glaceau Vitamin Water- which helped that company grow very rapidly and was eventually sold to Coca-Cola for $4.1 billion in 2007; resulting in a very high return for Verlinvest. Do not be surprised to see something similar develop here in the very near future.

The company's product line also includes Resurgex Select, a nutritional formula for cancer patients undergoing chemotherapy or radiation treatments; Resurgex and Resurgex Plus, which provide nutritional support following a patient's treatment; and Resurgex Essential and Resurgex Essential Plus, a ready-to-drink product line for the long-term care-geriatric markets. That line of products has been very well received for various medical, geriatric and nutritional applications.

This is a very rare opportunity for investors in the penny world to pick up shares of a company whose plans include a future listing on a major stock exchange. This stock could see huge gains even on the first day of the alert due to it's very low price.

Investors may keep in mind that shares for company's like Hansen's Natural were once trading below 10 cents. Today they are a $43 per share stock (Nasdaq:HANS).

 

Disclosure: Long MBTG.OB




"Featured Content" profiles are meant to provide awareness of these companies to investors in the small-cap and growth equity community and should not in any way come across as a recommendation to buy, sell or hold these securities. BiomedReports is not paid or compensated by newswires to disseminate or report news and developments about publicly traded companies, but may from time to time receive compensation for advertising, data, analytics and investor relation services from various entities and firms. Full disclosures should be read in the 'About Us Section'.

Add this page to your favorite Social Bookmarking websites
Digg! Reddit! Del.icio.us! Mixx! Google! Live! Facebook! Technorati! StumbleUpon! MySpace! Yahoo!

blog comments powered by Disqus
 

Newsletter